Diasorin Gets FDA 510(k) Clearance for New Multiplexing Platform
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
Researchers developed a urine test to measure the severity of the serious disease cystic fibrosis and assess the effect of new treatments.
Researchers have identified a protein leakage related to chronic airway diseases that could help determine the severity of asthma and COPD.
NanoPin’s diagnostic platform using Thermo Fisher’s advanced LC-MS technology will create sensitive clinical assays for infectious disease.
Read MoreThe Pulmonary Fibrosis Foundation has announced a new collaboration that could speed up the development of targeted treatments for individuals with idiopathic pulmonary fibrosis.
Read MoreRoutine use of the EDX RP positive run control enables laboratories to meet the requirements of their individualized quality control plans, including evaluation of reagent lot changes and new shipments.
Read MoreThe panel tests nasopharyngeal swabs for the most common respiratory viruses and bacteria.
Read MoreThe test enables highly automated screening for latent tuberculosis.
Read MoreThe Headstart system is designed for home monitoring and integrates a simple, easy-to-use diagnostic with a reader and mobile phone app to capture patient-specific health data.
Read MoreIGeneX’s new BCA assays are simple and cost-effective tests that give either a positive or negative result for exposure to Borrelia spp.
Read MoreThe company will receive funding to provide the breath biopsy component of a research initiative designed to provide new insights into the mechanisms of response and nonresponse to treatment for seven immune-mediated diseases.
Read MorePositive and negative controls are designed to help laboratories deliver reliable MTB-RIF testing results.
Read MoreThe funding will enable Lophius to expand clinical performance data and finalize design of the assay for use on automated platforms.
Read MoreA study by Karolinska Institute researchers shows that an algorithm used in a mobile phone app can efficiently manage uncontrolled asthma.
Read MoreStudy subjects with uncontrolled asthma had substantially higher levels of local IL-26 in their airways, when compared with subjects with controlled asthma.
Read MoreAccess to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals.
Read MoreThe panel is the first offering in a deep and broad pipeline of assays planned for QIAstat-Dx in the United States.
Read MoreThe study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read More